Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
Criscitiello C, Viale G, Curigliano G, et al. Profile ofbuparlisib and its potential in the treatment of breast cancer:evidence to date. Breast Cancer (Dove Med Press).2018;10:23–29.On page 23, Giuseppe Curigliano’s affiliation was incorrcectlylisted as European Institute of Onco...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2018
|
| Subjects: | |
| Online Access: | https://doaj.org/article/cf53a45a28df41ae9d9237ca439bd00c |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Criscitiello C, Viale G, Curigliano G, et al. Profile ofbuparlisib and its potential in the treatment of breast cancer:evidence to date. Breast Cancer (Dove Med Press).2018;10:23–29.On page 23, Giuseppe Curigliano’s affiliation was incorrcectlylisted as European Institute of Oncology, Milan, Italy.It should be Department of Oncology and Hemato-Oncology,Division of Early Drug Development for Innovative Therapy,University of Milan, European Institute of Oncology, Milan,Italy.Read the original article |
|---|